PT  - JOURNAL ARTICLE
AU  - Joller, Peter
AU  - Cabaset, Sophie
AU  - Maurer, Susanne
TI  - Influence of a Dietary Supplement on the Gut Microbiome of Overweight Young Women
AID  - 10.1101/2020.02.26.20027805
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.26.20027805
4099  - http://medrxiv.org/content/early/2020/02/27/2020.02.26.20027805.short
4100  - http://medrxiv.org/content/early/2020/02/27/2020.02.26.20027805.full
AB  - Background The importance of the gut microbiome cannot be overstated. Besides the help in digestion, it influences the immune system, produces immunologic and neurologic communication molecules, hormones and vitamins. The gut microbiome is also involved in controlling the BMI (Body Mass Index).Objectives We attempted to influence the gut microbiome with a herbal yeast-based dietary supplement in 26 women (BASEC ID 2016-02162; ClinicalTrials.gov NCT03223987, BS2016.1) with a BMI between 30 and 35 and and aged 25 to 35 years within 3 weeks. The clinical trial was conducted in accordance with the Declaration of Helsinki. Our hypothesis was that the supplement modifies the microbiome individually by more than 20%.Methods With shotgun sequencing in the 2 stool samples of each participant we found 68 bacterial species.Results The microbiome was altered by more than 20%. Five bacterial species were identical to probiotic species known as good butyrate producers and described as beneficial for the gut. Seventy percent of our study cohort showed an increase in the majority of these beneficial microbes during the study. The ratio of Firmicutes to Bacteroidetes is an important parameter in analyzing overweight persons. Twelve of the participants initially showed a F/B ratio (Firmicutes to Bacteroidetes ratio) above 1.6. After three weeks, five of these women normalized.Conclusions A baker’s yeast-based food supplement is able to modulate the gut microbiome of overweight young women within 3 weeks.Lay Summary Twenty-six overweight women 25 to 35 years old took an alimentary supplement consisting of plasmolyzed herbal baker’s yeast during three weeks. The goal was to influence the gut bacteria (microbiome). In the stool samples by molecular techniques we could show that the amount of individual bacteria in our cohort changed by more than 20% within the 3 weeks. Some the bacteria found are described as beneficial in the scientific literature. Over 70% of the participants showed an increase in the majority of these advantageous microbes.Firmicutes and Bacteroidetes are the two major phyla in our microbiome. The ratio of these phyla is associated with the body weight. The more Bacteroidetes, the lower the ratio and the body weight. During ingestion of the supplement, in 14 participants the ratio became lower.Competing Interest StatementConflict of interest: P.J none, S.C employee of Bio-Strath, S.M noneClinical TrialClinicalTrials.gov NCT03223987, BS2016.1Funding StatementFinancial funding was from Bio-Strath AG, Mühlebachstrasse 38, 8032 Zurich, Switzerland. PJ has been paid by the hour; SM by proband and the hour. SC received a wage.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the corresponding authorBMIBody Mass IndexCDCrohn’s DiseaseF/BFirmicutes to Bacteroidetes ratioGALTGut-Associated Lymphoid TissueHMPHuman Microbiome ProjectKEGGKyoto Encyclopedia of Genes and Genomes Orthology GroupsOTUOperational Taxonomic Unit, SCFA Short-Chain Fatty AcidsSMSShotgun Metagenomic Sequencing